Understanding NASH (Non-Alcoholic Steatohepatitis)

Publicēšanas datums 8 nov 2019
Skatījumi 28 580
16

Non-alcoholic steatohepatitis (NASH) is a growing public health issue, affecting an estimated three to five percent of the global adult population. It typically progresses slowly with few - if any - obvious or visible symptoms, making it a largely unrecognized and underdiagnosed disease. Learn more about how NASH develops and progresses in the body, as well as our approach to uncovering potential treatments.
Understanding NASH (Non-Alcoholic Steatohepatitis)

Pfizer